Polyurethane–Cardiolipin Nanoparticle-Modified Decellularized Scaffold-Based Vascular Patches for Tissue Engineering Applications,ACS Applied Bio Materials

当前位置： X-MOL 学术 › ACS Appl. Bio Mater. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Polyurethane–Cardiolipin Nanoparticle-Modified Decellularized Scaffold-Based Vascular Patches for Tissue Engineering Applications
ACS Applied Bio Materials ( IF 4.6 ) Pub Date : 2019-04-03 , DOI: 10.1021/acsabm.9b00079
Haomiao Zhu ₁ , Lei Fu ₁ , Lei He ₁ , Jun Zhang ₁ , Luxia Zhang ₁ , Lutao Yang ₁ , Yajuan Li ₁ , Yue Zhao ₁ , Yutong Wang ₂ , Hong Mo ₁ , Jian Shen ₁

Affiliation

Vascular patches based on a decellularized scaffold (DCS) have received considerable attention for the treatment of vascular defects caused by cardiovascular diseases. In this work, we fabricated a polyurethane–cardiolipin/polyurethane composite film (PU–CL/PU) by cosedimentating PU–CL nanoparticles in a PU-saturated ethanol solution onto a PU film and evaluated the biocompatibility of the composite film. We also fabricated a PU–CL/PU/DCS vascular patch (CLVP) and investigated its in vivo performance in a mouse model. The PU–CL/PU film showed improved biocompatibility features, such as a prolonged in vitro coagulation time, improved nonhemolytic properties, enhanced resistance to platelet adhesion, reduced cytotoxicity, and enhanced affinity for endothelial progenitor cells. The B ultrasound and the Doppler spectrum results indicated that the CLVP maintained blood vessel patency 30 days after implantation. In addition, endothelialization at the surgical site was achieved. Therefore, the CLVP may have great potential for the treatment of diseased or damaged blood vessels.

更新日期：2019-04-04

点击分享查看原文

点击收藏

阅读更多本刊新发论文本刊介绍/投稿指南